Radcliffe Capital Management, L.P. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTU and the CUSIP is G1125A124. A total of 60 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q1 2021$4,014,000405,9000.16%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2021
NameSharesValueWeighting ↓
HGC Investment Management Inc. 1,101,900$11,108,0000.80%
Sage Rock Capital Management LP 573,800$5,784,0000.76%
Cohen & Co Financial Management, LLC 100,000$1,008,0000.64%
Cowen Investment Management LLC 125,000$1,260,0000.33%
ARISTEIA CAPITAL, L.L.C. 1,149,010$11,582,0000.23%
Context Capital Management, LLC 200,000$2,016,0000.19%
Arena Capital Advisors, LLC- CA 200,000$2,016,0000.17%
Wealthspring Capital LLC 60,536$611,0000.15%
First Trust Capital Management L.P. 90,000$907,0000.14%
BCK CAPITAL MANAGEMENT LP 26,730$269,0000.14%
View complete list of BIOTECH ACQUISITION COMPANY shareholders